References
- GauvainCMornexJFPisonCHealth-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experienceCOPD201512Suppl 14651
- EdgarRGPatelMBaylissSCrossleyDSapeyETurnerAMTreatment of lung disease in alpha-1 antitrypsin deficiency: a systematic reviewInt J Chron Obstruct Pulmon Dis2017121295130828496314
- ShahPLHerthFJvan GeffenWHDesleeGSlebosDJLung volume reduction for emphysemaLancet Respir Med20175214715627693408
- DesléeGMalHDutauHLung volume reduction coil treatment vs usual care in patients with severe emphysema: The REVOLENS randomized clinical trialJAMA2016315217518426757466
- HartmanJETen HackenNHKloosterKBoezenHMde GreefMHSlebosDJThe minimal important difference for residual volume in patients with severe emphysemaEur Respir J20124051137114122441742
- JonesPWSt. George’s Respiratory Questionnaire: MCIDCOPD200521757917136966
- GøtzschePCJohansenHKIntravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung diseaseCochrane Database Syst Rev20169CD00785127644166
- HillerdalGMindusSOne- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case seriesRespiration201488432032825227936
- TuohyMMRemundKFHilfikerRMurphyDTMurrayJGEganJJEndobronchial valve deployment in severe α-1 antitrypsin deficiency emphysema: a case seriesClin Respir J201371455222236390